ÂÜÀòÂÒÂ×

Danhua Chen, Ph.D. has extensive experience in the pharmaceutical industry, with a strong focus on analytical chemistry and technology. Currently, they hold the position of Executive Director of Chemistry and Technology at Travere Therapeutics. In this role, they oversee various responsibilities such as managing CMOs for API manufacturing, conducting suitability verification and validation of processes and methods, and writing technical reports.

Prior to their current position, Dr. Chen held positions at Celgene (now BMS), Teva Pharmaceuticals, Pfizer, Anadys Pharmaceuticals (now Roche), Alliance Pharmaceuticals, and Ionis Pharmaceuticals, Inc. In these roles, they led teams and projects in areas such as analytical method development, validation, and transfer, as well as analytical research and development. Danhua also collaborated with external partners and played a crucial role in project decision making.

Overall, Dr. Chen's work experience demonstrates their expertise in analytical sciences and their ability to manage and lead teams in pharmaceutical companies.

Danhua Chen, Ph.D. pursued a Doctor of Philosophy (Ph.D.) in Biotechnology at the University of Wisconsin-Madison. Additionally, they also completed a Doctor of Philosophy (Ph.D.) in Analytical Chemistry at Wuhan University.